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Basic fibroblast growth factor modulates cell cycle of human umbilical cord-derived 
mesenchymal stem cells. 
 
ABSTRACT 
Background: Mesenchymal stem cells (MSC) have great potential in regenerative medicine, 
immunotherapy and gene therapy due to their unique properties of self-renewal, high 
plasticity, immune modulation and ease for genetic modification. However, production of 
MSC at sufficient clinical scale remains an issue as in vitro generation of MSC inadequately 
fulfils the demand with respect to patients. Objectives: This study has aimed to establish 
optimum conditions to generate and characterize MSC from human umbilical cord (UC-
MSC). Materials and methods: To optimize MSC population growth, basic fibroblast growth 
factor (bFGF) was utilized in culture media. Effects of bFGF on expansion kinetics, cell cycle, 
survival of UC-MSC, cytokine secretion, expression of early stem-cell markers and 
immunomodulation were investigated. Results: bFGF supplementation profoundly enhanced 
UC-MSC proliferation by reducing population doubling time without altering 
immunophenotype and immunomodulatory function of UC-MSC. However, cell cycle 
studies revealed that bFGF drove the cells into the cell cycle, as a higher proportion of cells 
resided in S phase and progressed into M phase. Consistent with this, bFGF was shown to 
promote expression of cyclin D proteins and their relevant kinases to drive UC-MSC to 
transverse cell cycle check points, thus, committing the cells to DNA synthesis. Furthermore, 
supplementation with bFGF changed the cytokine profiles of the cells and reduced their 
apoptotic level. Conclusion: Our study showed that bFGF supplementation of UC-MSC 
culture enhanced the cells' growth kinetics without compromising their nature. 
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